Home › Micro Therapeutics, Inc. › Solitaire™ X-PACK
Solitaire™ X-PACK
Micro Therapeutics, Inc. · Model XPACK217 · UDI-DI 00763000270339
2
510(k) clearances
96
Adverse events (2 deaths)
3
Recalls
12
Facilities
Description
KIT XPACK217 V01 US
Recalls
| Date | Firm | Reason |
|---|---|---|
| 2024-04-23 | Stryker Neurovascular | Neurovascular devices did not meet the minimum sample size required for endotoxin testing during manufacturing processes and are out of compliance with the AAMI ST72 standard, so t |
| 2024-04-23 | Stryker Neurovascular | Neurovascular devices did not meet the minimum sample size required for endotoxin testing during manufacturing processes and are out of compliance with the AAMI ST72 standard, so t |
| 2020-09-21 | Stryker Neurovascular | Increase in fracture complaints of the flexible, tapered core wire, resulting in stent retriever separation from the core wire during use. The stent retriever can be left behind in |
Query this across every FDA database — by API.
Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.
Get your free API keyRead the docsData compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.